Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Nitrogenase molybdenum-iron protein (MoFe protein) is the catalytic component of the nitrogenase enzyme system, primarily found in diazotrophic bacteria and archaea such as Azotobacter vinelandii (UniProt: P07328, P07329). It is an alpha2beta2 heterotetramer that contains two unique metal clusters: the P-cluster ([8Fe-7S]) and the iron-molybdenum cofactor (FeMo-co), which serves as the active site for substrate reduction (PubMed: 1313187). Its primary biological function is the reduction of atmospheric dinitrogen (N2) to ammonia (NH3), a process essential for the global nitrogen cycle and the production of bioavailable nitrogen for all life forms. The MoFe protein works in conjunction with the Fe protein (Component II), which provides the high-energy electrons and ATP hydrolysis required to drive the reduction process. While the MoFe protein is not a target for human therapeutic drugs, it is a major focus of agricultural biotechnology for developing sustainable alternatives to industrial fertilizers. The enzyme is highly sensitive to oxygen, which causes irreversible oxidative damage to its metal clusters, posing a significant challenge for its expression in aerobic organisms. Research into its mechanism often utilizes inhibitors like carbon monoxide and cyanide to probe the electronic states of the FeMo-cofactor during catalysis.
Not applicable as there are no known therapeutic drugs targeting this protein; however, its catalytic mechanism involves ATP-dependent electron transfer from the Fe protein (Component II) to the FeMo-cofactor (M-cluster) for the reduction of dinitrogen (N2) to ammonia (NH3).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitrogenase molybdenum-iron protein (MoFe protein) (MoFe protein).